VEEV stock icon

Veeva Systems

210.13 USD
+3.29
1.59%
At close Oct 10, 4:00 PM EDT
After hours
210.13
+0.00
0.00%
1 day
1.59%
5 days
1.78%
1 month
-5.30%
3 months
15.44%
6 months
-0.37%
Year to date
11.07%
1 year
-1.75%
5 years
39.82%
 

About: Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Employees: 7,172

0
Funds holding %
of 6,740 funds
0
Analysts bullish %
of 17 analysts

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

23% more repeat investments, than reductions

Existing positions increased: 368 | Existing positions reduced: 298

8% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 92

1% more funds holding

Funds holding: 889 [Q1] → 896 (+7) [Q2]

1.11% less ownership

Funds ownership: 79.77% [Q1] → 78.66% (-1.11%) [Q2]

13% less call options, than puts

Call options by funds: $173M | Put options by funds: $200M

22% less capital invested

Capital invested by funds: $29.7B [Q1] → $23.3B (-$6.48B) [Q2]

33% less funds holding in top 10

Funds holding in top 10: 18 [Q1] → 12 (-6) [Q2]

Research analyst outlook

17 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$192
9%
downside
Avg. target
$239
14%
upside
High target
$286
36%
upside

17 analyst ratings

12 positive
71%
neutral
29%
negative
0%
Exane BNP Paribas
Andrew DeGasperi
100% 1-year accuracy
1 / 1 met price target
36%upside
$286
Outperform
Initiated
8 Oct 2024
Guggenheim
Jack Wallace
56% 1-year accuracy
5 / 9 met price target
19%upside
$249
Buy
Maintained
1 Oct 2024
JP Morgan
Anne Samuel
47% 1-year accuracy
7 / 15 met price target
1%downside
$208
Neutral
Maintained
9 Sept 2024
Truist Securities
Jailendra Singh
42% 1-year accuracy
14 / 33 met price target
1%downside
$207
Hold
Maintained
3 Sept 2024
TD Cowen
Charles Rhyee
14% 1-year accuracy
1 / 7 met price target
9%downside
$192
Hold
Maintained
29 Aug 2024

Financial journalist opinion

Based on 14 articles about VEEV published over the past 30 days

Charts implemented using Lightweight Charts™